- Feature Paper
- Conference Report
Non-Clinical Contribution to Clinical Trials during Lead Optimization Phase
- Lázara Martínez Muñoz
This manuscript comments on guidelines related to requirements for clinical trials for new drugs and the importance of considering regulatory criteria in the planning phase, in order to enhance the utility of data generated in basic research. Suggest...